TR200003206T2 - İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları. - Google Patents
İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları.Info
- Publication number
- TR200003206T2 TR200003206T2 TR2000/03206T TR200003206T TR200003206T2 TR 200003206 T2 TR200003206 T2 TR 200003206T2 TR 2000/03206 T TR2000/03206 T TR 2000/03206T TR 200003206 T TR200003206 T TR 200003206T TR 200003206 T2 TR200003206 T2 TR 200003206T2
- Authority
- TR
- Turkey
- Prior art keywords
- diseases
- cell proliferation
- treatment
- pathological cell
- indole derivatives
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 230000004663 cell proliferation Effects 0.000 title abstract 2
- 230000003211 malignant effect Effects 0.000 title abstract 2
- 230000001575 pathological effect Effects 0.000 title abstract 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 abstract 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Abstract
Bulus, (I) formülünün bis-indolil bilesiklerinin tirosin kinaz inhibitörlerine, bahsedilen inhibitörleri ihtiva eden tibbi maddelere ve bunlarin patolojik hücre çogalmasinin neden oldugu habis hastaliklar ve diger hastaliklarin tedavi edilmesinde kullanimlarina iliskindir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19819835 | 1998-05-04 | ||
DE19838506A DE19838506C2 (de) | 1998-05-04 | 1998-08-25 | Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200003206T2 true TR200003206T2 (tr) | 2001-07-23 |
Family
ID=26045937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/03206T TR200003206T2 (tr) | 1998-05-04 | 1999-04-22 | İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları. |
Country Status (22)
Country | Link |
---|---|
US (2) | US6407102B1 (tr) |
EP (1) | EP1109785B1 (tr) |
JP (1) | JP2002514572A (tr) |
CN (1) | CN1151127C (tr) |
AT (1) | ATE230394T1 (tr) |
AU (1) | AU752464B2 (tr) |
BG (1) | BG104996A (tr) |
BR (1) | BR9911017A (tr) |
CA (1) | CA2330756C (tr) |
CZ (1) | CZ20003960A3 (tr) |
DE (1) | DE59903921D1 (tr) |
DK (1) | DK1109785T3 (tr) |
ES (1) | ES2190221T3 (tr) |
HK (1) | HK1038354A1 (tr) |
HU (1) | HUP0102563A3 (tr) |
IL (1) | IL139056A0 (tr) |
NO (1) | NO317261B1 (tr) |
NZ (1) | NZ507735A (tr) |
PL (1) | PL346840A1 (tr) |
SK (1) | SK16352000A3 (tr) |
TR (1) | TR200003206T2 (tr) |
WO (1) | WO1999057117A2 (tr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL346840A1 (en) | 1998-05-04 | 2002-02-25 | Zentaris Ag | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
US6719520B2 (en) | 1998-10-08 | 2004-04-13 | Smithkline Beecham Corporation | Method and compounds |
ES2234300T3 (es) * | 1998-10-08 | 2005-06-16 | Smithkline Beecham Plc | 3-(3-cloro-4-hidroxifenilamino)-4-(2-nitrofenil)-1h-pirrol-2,5-diona como inhibidor de glucogeno cinasa-3 (gsk-3)sintetasa. |
JP2004501910A (ja) * | 2000-06-28 | 2004-01-22 | イーライ・リリー・アンド・カンパニー | 新規なsPLA2インヒビター |
CA2416946A1 (en) | 2000-07-28 | 2003-01-22 | Sumitomo Pharmaceuticals Co., Ltd. | Pyrrole derivatives |
TW557298B (en) * | 2000-08-14 | 2003-10-11 | Ciba Sc Holding Ag | A compound, a photopolymerizible composition, a process for producing coatings and a method for causing a photoinitiator to accumulate at the surface of coatings |
US20030032625A1 (en) * | 2001-03-29 | 2003-02-13 | Topo Target Aps | Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors |
DE10143079A1 (de) * | 2001-09-03 | 2003-05-15 | Zentaris Ag | Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel |
US20050267303A1 (en) * | 2001-09-04 | 2005-12-01 | Zentaris Ag | Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals |
JPWO2003063861A1 (ja) * | 2002-01-30 | 2005-05-26 | 住友製薬株式会社 | 線維化抑制剤 |
US6800655B2 (en) | 2002-08-20 | 2004-10-05 | Sri International | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
EP1747014A4 (en) * | 2004-05-03 | 2007-09-12 | Ilypsa Inc | MODULATION OF LYSOPHOSPHATIDYLCHOLINE AND TREATMENT OF CONDITIONS INDUCED BY A DIET |
EP1951315A2 (en) * | 2005-11-03 | 2008-08-06 | Ilypsa, Inc. | Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
JP2009514893A (ja) * | 2005-11-03 | 2009-04-09 | イリプサ, インコーポレイテッド | 多価インドール化合物およびホスホリパーゼa2インヒビターとしてのその使用 |
EP1948656A2 (en) * | 2005-11-03 | 2008-07-30 | Ilypsa, Inc. | Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
CA2627352A1 (en) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
WO2007056280A1 (en) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
US20090142832A1 (en) * | 2007-11-29 | 2009-06-04 | James Dalton | Indoles, Derivatives, and Analogs Thereof and Uses Therefor |
PL2448938T3 (pl) | 2009-06-29 | 2014-11-28 | Incyte Holdings Corp | Pirymidynony jako inhibitory PI3K |
CN101704828A (zh) * | 2009-11-04 | 2010-05-12 | 中国科学院昆明植物研究所 | 山橙素类双吲哚化合物,其药物组合物及其制备方法和用途 |
WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
US8680108B2 (en) * | 2009-12-18 | 2014-03-25 | Incyte Corporation | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
US9193721B2 (en) | 2010-04-14 | 2015-11-24 | Incyte Holdings Corporation | Fused derivatives as PI3Kδ inhibitors |
US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
TW201249844A (en) | 2010-12-20 | 2012-12-16 | Incyte Corp | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
KR101982475B1 (ko) | 2011-09-02 | 2019-05-27 | 인사이트 홀딩스 코포레이션 | Pi3k 억제제로서 헤테로시클릴아민 |
AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
ES2843522T3 (es) | 2015-02-27 | 2021-07-19 | Incyte Corp | Sales del inhibidor de PI3K y procesos para su preparación |
US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
CN106317169B (zh) * | 2015-06-23 | 2019-07-02 | 首都医科大学 | 双吲哚-二肽衍生物,其合成,抗血栓活性和制备抗血栓剂的应用 |
WO2018024172A1 (en) * | 2016-08-05 | 2018-02-08 | The University Of Hong Kong | Platinum complexes and methods of use thereof |
CN114364798A (zh) | 2019-03-21 | 2022-04-15 | 欧恩科斯欧公司 | 用于治疗癌症的Dbait分子与激酶抑制剂的组合 |
WO2020245208A1 (en) | 2019-06-04 | 2020-12-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cd9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis |
AU2020378630A1 (en) | 2019-11-08 | 2022-05-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598583A (en) * | 1968-08-09 | 1971-08-10 | Itek Corp | Indomethylene dye bases and their utilization in photographic processes and compositions |
FR2688220A1 (fr) * | 1992-03-06 | 1993-09-10 | Adir | Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
WO1994024117A1 (en) * | 1993-04-22 | 1994-10-27 | Nippon Shinyaku Co., Ltd. | Benzofurancarboxylic acid derivative and pharmaceutical composition |
US5656643A (en) | 1993-11-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
ES2236702T3 (es) * | 1993-12-23 | 2005-07-16 | Eli Lilly And Company | Inhibidores de la proteina quinasa c. |
JPH08295688A (ja) * | 1995-04-28 | 1996-11-12 | Sharp Corp | ビスアゾ化合物、その中間体及びそれらの製造方法、並びにビスアゾ化合物を含有する電子写真感光体 |
DE19547263C2 (de) * | 1995-12-07 | 1999-04-29 | Cardiotec Inc | Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
PL346840A1 (en) | 1998-05-04 | 2002-02-25 | Zentaris Ag | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
-
1999
- 1999-04-22 PL PL99346840A patent/PL346840A1/xx not_active Application Discontinuation
- 1999-04-22 AU AU44975/99A patent/AU752464B2/en not_active Ceased
- 1999-04-22 SK SK1635-2000A patent/SK16352000A3/sk unknown
- 1999-04-22 JP JP2000547087A patent/JP2002514572A/ja not_active Withdrawn
- 1999-04-22 HU HU0102563A patent/HUP0102563A3/hu unknown
- 1999-04-22 DK DK99927711T patent/DK1109785T3/da active
- 1999-04-22 CA CA002330756A patent/CA2330756C/en not_active Expired - Fee Related
- 1999-04-22 WO PCT/DE1999/001214 patent/WO1999057117A2/de not_active Application Discontinuation
- 1999-04-22 DE DE59903921T patent/DE59903921D1/de not_active Expired - Fee Related
- 1999-04-22 BR BR9911017-2A patent/BR9911017A/pt not_active IP Right Cessation
- 1999-04-22 AT AT99927711T patent/ATE230394T1/de not_active IP Right Cessation
- 1999-04-22 EP EP99927711A patent/EP1109785B1/de not_active Expired - Lifetime
- 1999-04-22 TR TR2000/03206T patent/TR200003206T2/tr unknown
- 1999-04-22 ES ES99927711T patent/ES2190221T3/es not_active Expired - Lifetime
- 1999-04-22 CZ CZ20003960A patent/CZ20003960A3/cs unknown
- 1999-04-22 IL IL13905699A patent/IL139056A0/xx not_active IP Right Cessation
- 1999-04-22 CN CNB998058033A patent/CN1151127C/zh not_active Expired - Fee Related
- 1999-05-04 US US09/305,115 patent/US6407102B1/en not_active Expired - Fee Related
-
2000
- 2000-10-24 NZ NZ507735A patent/NZ507735A/xx unknown
- 2000-10-27 NO NO20005448A patent/NO317261B1/no unknown
- 2000-11-28 BG BG104996A patent/BG104996A/xx unknown
-
2001
- 2001-12-27 HK HK01109122A patent/HK1038354A1/xx not_active IP Right Cessation
-
2002
- 2002-05-03 US US10/137,653 patent/US6812243B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BG104996A (en) | 2001-07-31 |
NO317261B1 (no) | 2004-09-27 |
NO20005448D0 (no) | 2000-10-27 |
SK16352000A3 (sk) | 2002-07-02 |
NZ507735A (en) | 2003-04-29 |
HUP0102563A3 (en) | 2003-04-28 |
CN1151127C (zh) | 2004-05-26 |
AU752464B2 (en) | 2002-09-19 |
HUP0102563A2 (hu) | 2001-11-28 |
PL346840A1 (en) | 2002-02-25 |
WO1999057117A3 (de) | 2001-04-12 |
AU4497599A (en) | 1999-11-23 |
EP1109785B1 (de) | 2003-01-02 |
HK1038354A1 (en) | 2002-03-15 |
ES2190221T3 (es) | 2003-07-16 |
CN1310705A (zh) | 2001-08-29 |
CA2330756A1 (en) | 1999-11-11 |
CA2330756C (en) | 2007-10-02 |
CZ20003960A3 (cs) | 2002-04-17 |
DE59903921D1 (de) | 2003-02-06 |
JP2002514572A (ja) | 2002-05-21 |
NO20005448L (no) | 2000-10-27 |
US6812243B2 (en) | 2004-11-02 |
DK1109785T3 (da) | 2003-04-22 |
US20030008898A1 (en) | 2003-01-09 |
US6407102B1 (en) | 2002-06-18 |
IL139056A0 (en) | 2001-11-25 |
EP1109785A2 (de) | 2001-06-27 |
BR9911017A (pt) | 2001-02-06 |
WO1999057117A2 (de) | 1999-11-11 |
ATE230394T1 (de) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200003206T2 (tr) | İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları. | |
TR200003514T2 (tr) | Pirol ikame edilmiş 2-indolinon protein kinaz inhibitörleri | |
TR200002980T2 (tr) | İnhibe edici etkiye sahip ikame edilmiş indolinonlar | |
TR200200928T2 (tr) | 2-pirazolin-5-on terkipleri | |
ATE324877T1 (de) | Behandlung von metastatischer krankheit | |
YU21401A (sh) | Tetrahidropiridoetri | |
LU91657I2 (fr) | Tocéranibe et ses dérivés pharmaceutiquement acceptables (PALLADIA®) | |
ATE292623T1 (de) | 2-indolinonderivate als modulatoren der proteinkinase-ativität | |
BR0215360A (pt) | Derivados de indolina úteis como inibidores de proteìna quinase | |
ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
DE69723863D1 (de) | Chinoline und deren therapeutische verwendung | |
TR200401316T4 (tr) | Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler | |
DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
EA200301005A1 (ru) | Замещенные в положении 6 индолиноны и их применение в качестве ингибиторов киназ | |
EE03771B1 (et) | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine | |
ATE427746T1 (de) | 5-methylindirubin zur verwendung in der behandlung von menschlichen festen tumoren | |
PT1051187E (pt) | Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt) | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
DE60010934D1 (de) | Medikamente geeignet zur Behandlung von proliferativen Erkrankungen | |
BR0113266A (pt) | Métodos para modular proteìnas quinase de linhagem múltipla e compostos protetores que modulam proteìnas quinase de linhagem múltipla | |
AR021502A1 (es) | Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso | |
DE60003214D1 (de) | Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen | |
ECSP003846A (es) | Pirroles sustituidos | |
TR200100476T2 (tr) | N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları. |